Amikacin: all 46 studies that test it
Page 1 of 1. Open to participants first (7), then studies with results posted, then the rest; newest registration first within each.
- Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform TrialNot yet recruitingNCT07485010Phase 2
- Bacteriophage Therapy for Mycobacterium Abscessus Pulmonary InfectionEnrolling by invitationNCT07228702Phase 1
- A Study to Evaluate Role of Inhaled Amikacin to Prevent Ventilator Associated Pneumonia in Patients With CirrhosisRecruitingNCT06808074Phase 4
- " Study of the Benefit of Nebulized Amikacin in the Treatment of Gram-negative Bacillus Pneumonia Acquired During Mechanical Ventilation in Patients Receiving Extracorporeal Membrane Veno-arterial Oxygenation "RecruitingNCT06602557Phase 2
- Amikacin Liposome Inhalation Suspension for Treatment of Mycobacterium Xenopi Pulmonary InfectionRecruitingNCT06585020Phase 2
- Preventing Acquired Resistance: Strengthen TB Treatment by Adding Amikacin in the First Treatment Week of Multidrug-resistant TuberculosisRecruitingNCT05555303Phase 2
- Finding the Optimal Regimen for Mycobacterium Abscessus TreatmentRecruitingNCT04310930Phase 2/3
- Validation of Patient Reported Outcome Measures in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium ComplexCompletedNCT04677543Phase 3Results posted
- Study of Dose Escalation of Liposomal Amikacin for Inhalation (ARIKAYCE™) - Extension PhaseCompletedNCT03905642Phase 2Results posted
- Open-label Safety Extension Study Assessing Safety and Tolerability of LAI in Patients Who Participated in Study INS-212CompletedNCT02628600Phase 3Results posted
- Study to Evaluate Efficacy of LAI When Added to Multi-drug Regimen Compared to Multi-drug Regimen AloneCompletedNCT02344004Phase 3Results posted
- Combined Administration of Nebulized Amikacin in Patients With Acute Exacerbation of Non-Cystic Fibrosis BronchiectasisCompletedNCT02081963Phase 4Results posted
- Antibiotic Prophylaxis for Transrectal Prostate BiopsyCompletedNCT01659866Phase 4Results posted
- Extension Study of Liposomal Amikacin for Inhalation in Cystic Fibrosis (CF) Patients With Chronic Pseudomonas Aeruginosa (Pa) InfectionCompletedNCT01316276Phase 3Results posted
- Study to Evaluate Arikayce™ in CF Patients With Chronic Pseudomonas Aeruginosa InfectionsCompletedNCT01315678Phase 3Results posted
- Liposomal Amikacin for Inhalation (LAI) for Nontuberculous MycobacteriaCompletedNCT01315236Phase 2Results posted
- Multidose Safety and Tolerability Study of Dose Escalation of Liposomal Amikacin for Inhalation (ARIKACE™)CompletedNCT00777296Phase 1/2Results posted
- Safety and Tolerability Study of 2 Dose Level of Arikayce™ in Patients With Bronchiectasis and Chronic Infection Due to Pseudomonas Aeruginosa.CompletedNCT00775138Phase 2Results posted
- Safety/Tolerability Study of Arikayce™ in Cystic Fibrosis Patients With Chronic Infection Due to Pseudomonas AeruginosaCompletedNCT00558844Phase 1/2Results posted
- Colistin and Meropenem Versus Amikacin and Meropenem for MDR Gram Negative Bacteria Regarding Efficacy and Safety.Active, not recruitingNCT07694700Phase 4
- Clinical Outcomes of Inhaled Amikacin in Ventilator Associated PneumoniaCompletedNCT07369336Phase 4
- A Study to Investigate Lung Deposition of Inhaled Amikacin-loaded Liposomes in Healthy Male ParticipantsCompletedNCT05999942Phase 1
- Early Versus Late Stopping of Antibiotics in Children With Cancer and High-risk Febrile NeutropeniaCompletedNCT04948463Phase 4
- Amikacin Pharmacokinetics to Optimize Dosing Recommendations in Neonates With Perinatal Asphyxia Treated With HypothermiaStatus unknownNCT04867993Not applicable
- Study to Evaluate ALIS (Amikacin Liposome Inhalation Suspension) in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium ComplexCompletedNCT04677569Phase 3
- Pharmacokinetic Evaluation and Local Tolerability of Dry Powder Amikacin Via the Cyclops™Status unknownNCT04249531Phase 1
- Fixed-dose Amikacin for Elderly UTIStatus unknownNCT04197739Phase 4
- Raja Isteri Pengiran Anak Saleha Appendicitis Treatment Without OperationTerminatedNCT03169114Not applicable
- Study Comparing Inhaled Amikacin Versus Placebo to Prevent Ventilator Associated PneumoniaCompletedNCT03149640Phase 3
- Liposomal Amikacin for Inhalation (LAI) in the Treatment of Mycobacterium Abscessus Lung DiseaseCompletedNCT03038178Phase 2
- DDI Study to Investigate Interaction Between Amikacin and POL7080CompletedNCT02897869Phase 1
- Amikacin Pharmacokinetic Profile in Plasma and Tissue After an Administration Using Impregnated Dressings in Burned Patient PopulationTerminatedNCT02872272Phase 4
- Nebulized Amikacin Versus Intravenous Amikacin in the Treatment of Nosocomial PneumoniaCompletedNCT02728518Not applicable
- Open-Label Phase 1 Study of Aerosolized Amikacin and Fosfomycin in Healthy VolunteersCompletedNCT02709265Phase 1
- Effect of Additional Nebulized Amikacin in Ventilator-Associated Pneumonia Caused by Gram Negative BacteriaCompletedNCT02574130Not applicable
- Antibiotic Nephrotoxicity in Adult Patients With Cystic FibrosisStatus unknownNCT02489955Not applicable
- Pharmacokinetic/Pharmacodynamic Evaluation Amikacin in Critically Ill Patients Admitted at the Emergency DepartmentCompletedNCT02365272Phase 4
- Inhaled Amikacin Treatment for Nontuberculous Mycobacterial Lung DiseaseWithdrawnNCT01528930Phase 2
- Study to Evaluate Arikace™ in CF Patients With Chronic Infection Due to Pseudomonas AeruginosaWithdrawnNCT01315691Phase 3
- Role of Antibiotics in Preventing Infection in Babies Born Through Meconium Stained LiquorCompletedNCT01290003Not applicable
- Impact of Imipenem With Amikacin Pharmacokinetic and PharmacodynamicCompletedNCT00950222Not applicable
- Pharmacokinetics of Nebulized Amikacin in Patients With Pneumonia Undergoing Mechanical VentilationStatus unknownNCT00861315Phase 2/3
- Nebulized Ceftazidime and Amikacin in Ventilator Associated PneumoniaCompletedNCT00786305Phase 2
- Standard vs. Biofilm Susceptibility Testing in Cystic Fibrosis (CF)CompletedNCT00153634Not applicable
- Once-Daily Amikacin Plus Cloxacillin in Febrile Neutropenic ChildrenCompletedNCT00129688Not applicable
- A Phase II/III Trial of Rifampin, Ciprofloxacin, Clofazimine, Ethambutol, and Amikacin in the Treatment of Disseminated Mycobacterium Avium Infection in HIV-Infected Individuals.CompletedNCT00000641Phase 2